AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2014
Nov 10, 2014
34097_dirs_2014-11-10_06559740-4ccf-4b57-99ae-7883731eda72.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Nemus Bioscience, Inc. (LGLRD)
CIK: 0001516551
Period of Report: 2014-10-31
Reporting Person: Berecz Elizabeth (Chief Financial Officer)
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10